Just watch out my little preashitty psycho shorty that your behind is not getting ripped wide open over the next few month. Oh I forgot you're just a psycho having fun, not any money in the market. And that is the last you hear from me; I'm not getting down to your level but once.
Morgan Stanley Selloff Spells Buying Opportunity
Shares have tumbled near 20% since late July but shares look cheap amid strength in wealth-management.
By JOHANNA BENNETT
Oct. 7, 2015 5:25 p.m. ET
Down roughly 20% since late July, Morgan Stanley has been the biggest loser among the four big U.S. investment banks. The stock tumbled with the broader market during its recent selloff. And Morgan, along with other banks, faced further pressure last month after the Federal Reserve decided against raising short-term interest rates.
Is it time to buy? RBC Capital Markets thinks so. Early Wednesday, analyst Fiona Swaffield upgraded Morgan Stanley (ticker: MS ) to Outperform from Sector Perform, while maintaining her $39 price target. She describes the stock’s recent selloff as an “overreaction.” Investors seem to agree as the stock is 1.4% higher to a recent $32.81.
A group of stocks such a biotech down this much shows that this market has been rigged to maximize profits for wallstreet. Biotech are the only place where profits are growing strongly due to innovation. This is crazy!
Prices would sky rock fast
The sinking tide took all ships down even so BioTech is not affected at all by the China problems, etc. Q3 earnings seems to come in strong and GILD will recover and then some.
With the current market storm and China problems, even so BioTech is not affected but the outgoing tide takes down all ships, I'll say that AMGN may only get to 200 by year end.
You got that right, you got a bit of a dead vat bounce, and then she goes down again